Information Updated: April 27th 2020
This is an AmbuBag device.
Spiro Wave is a low-cost automatic resuscitator that helps hospitals expand their capacity to care for patients with critical ventilation needs. The cost per unit is expected to be between $2,500 and $5,000
(more details can be found on the project websites - see links below)
This ventilator is based on the MIT E-Vent Project. It has been developed by a consortium based in New York, coordinated by New Lab and in collaboration with MIT engineers, 10xBeta, OtherLab and Boyce. Funded by Rockefeller Philanthropy Advisors. The ventilators are currently being manufactured for use in New York with plans to scale.
The team is engaged in a managed open-source process to safely and rapidly scale the production and distribution of Spiro Waves. Qualified manufacturers with a proven track record can contact the team via their website.
Spiro Wave is provided for use under the FDA Emergency Use Authorization for ventilators, which authorizes its use for the duration of the COVID-19 public health emergency. This device is not FDA cleared or approved.
Publicly available: Yes
Countries where available: Received FDA Emergency Use Authorization for use during the COVID-19 public health emergency - April 17th 2020
Offered or can be licensed for local manufacture: Yes
If you are aware of any updates to the Spiro Wave project please complete the form or send an email to [email protected]